scroll to top.svgleft arrow.svgright arrow-1.svg
AAAAI logo.svg
share_on_x_twitter.svgShare on Facebook.svgshare on Linkedin.svg

Board of Directors June Meeting Highlights

The AAAAI Board of Directors met June 16-18, 2023, in Cincinnati, Ohio. The members of the Board of Directors appreciate the work of AAAAI committee members and chairs as they strive toward the AAAAI mission to advance the knowledge and practice of allergy, asthma and immunology for optimal patient care. AAAAI President, Jonathan A. Bernstein, MD, FAAAAI, also hosted the Board and staff at his home for dinner, pictured below.
Over the course of the meeting, a number of significant decisions and actions were made. Here are the highlights:
A number of requests were granted approval, including funding for the next Joint Board Review Course, continued funding and expansion of the Chrysalis Project as well as additional funding for travel scholarships. The Board also approved continued funding for AAAAI leadership programs such as the Leadership Institute and the Leadership Development Course to be held at the 2024 AAAAI Annual Meeting.
Additionally, the AAAAI Foundation was granted approval for a new five-year lectureship to be announced at the 2024 AAAAI Annual Meeting, with the first presentation at the 2025 AAAAI Annual Meeting.
Presidential Presentations
Dr. Bernstein shared more on his presidential initiatives, including:
  • The Volunteerism Addressing Environmental Disparities in Allergy (VAEDIA) Task Force and its plans for collaborating with other professional medical organizations to create community projects moving forward.
  • A new initiative to host forums, possibly in conjunction with the AAAAI Annual Meeting, addressing health disparities in different regions of the world.
Paul V. Williams, MD, FAAAAI, President-Elect, provided a first look at his coming presidential initiatives, including:
  • A planned task force on the environment and climate change to expand knowledge among members concerning the impact of the environment on allergic disease.
  • Efforts to educate on climate change and its disproportionate impact on the underprivileged, environmental racism and women’s health.
  • Greening of Allergy Practices, a program to educate people on the impact practice has on the environment and how to create a “green practice."
A number of other projects and topics were discussed, including the creation of a task force to address discrepancies in the correct application of CPT® code 95165, as well as funding for a medical writer/illustrator to assist with PDT projects and other educational efforts moving forward.
The Board also approved the merger of the Allergic Fungal Respiratory Diseases Committee and Microbes in Allergy and Asthma Committee with a new name of the Microbial Triggers of Diseases Committee. More information about this committee and ways to join will be available soon.
In addition, the three divisions of the Board of Directors—Education, Practice & Policy and Research & Training—met individually to discuss committee activities.
The next Board of Directors meeting
November 3-5, 2023
Washington, DC